Skip to main content
OpenTrials
Completed

NCT Number: NCT02020681

Effect of Curodont Repair or Placebo on the Remineralisation in Patients With Class 5 Carious Lesions

The purpose of this study is to evaluate the therapeutic benefit of Curodont Repair for the treatment of early buccal carious lesions compared to placebo.

Completed

Looking for future studies?

Notify Me

Key information

Age range

14 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Geneva - Devision of Cariology and Endodontology

Geneva, 1205, Switzerland

About this study

All study participants must have two early class V carious lesions in need of a treatment but not of an invasive treatment (split-mouth design). One lesion will be treated with Curodont Repair and one with placebo as control (single application). 3 months later fluoride (Duraphat) will be applied on both lesions. Study duration is 9 months. For assessment visual and tactile evaluation, pictures, ECM, Diagnodent Pen, Canary System, VAS is used.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Two class V carious lesions which do not require an invasive treatment
  • Size and form of the lesions: the lesions must both be fully visible and assessable and accessible
  • Patients must be able and willing to observe good oral hygiene throughout the study

-≥ 20 teeth

  • Permanent dentition and ≤ 65 years
  • Willing and able to attend the on-study visits
  • Willing and able to understand all study-related procedures
  • Written informed consent before participation in the study
  • Negative pregnancy test for women of childbearing potential

Exclusion criteria

  • The two study lesions must not be on adjacent teeth
  • No adjacent restoration on study tooth surface
  • Fluoride varnish application < 6 months prior to study treatment
  • Patient suffers from diabetes
  • Evidence of tooth erosion (due to excessive acidic drink consumption or reflux)
  • History of head and neck illnesses (e.g. head/neck cancer)
  • Any pathology or concomitant medication affecting salivary flow or dry mouth
  • Any metabolic disorders affecting bone turnover
  • Concurrent participation in another clinical trial with an investigational drug or device or participation in another clinical trial with an investigational drug or device within 30 days prior to study entry
  • Pregnant and lactating woman

Treatment and study plan

Curodont Repair

Device

Self-assembling peptide, biomimetic re-mineralisation

Other names: P11-4

Placebo

Other

Formulation of Curodont Repair without the peptide P11-4

Fluoride

Device

Single application on day D90

Primary outcomes

  1. The primary efficacy outcome is the difference of the change in the lesion size assessed by morphometry (standardised pictures) between investigational medical device and placebo group.

    Time frame: D0, D30, D90, D270

    Change of lesion size relative to baseline between study groups and different time points

Secondary outcomes

  1. Difference in the change of Diagnodent Pen values between investigational medical device and placebo group.

    Time frame: D0, D30, D90, D180, D270

    only descriptively analysed

  2. Change in lesion's progression assessed by VAS between investigational medical device and placebo group.

    Time frame: D0, D30, D90, D180, D270

    only descriptively analysed

Sponsors and collaborators

Lead sponsor

Credentis AG

Industry

Registry information

Official study title

Effect of Curodont Repair or Placebo on the Remineralisation in Patients With Class 5 Carious Lesions: A Mono-centre, Split-mouth, Double-blinded, Placebo Controlled, Randomised, Post Marketing Clinical Study

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Dec 25, 2013
Registry last updated
Aug 30, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.